-
公开(公告)号:EP3177295A4
公开(公告)日:2018-06-13
申请号:EP15829427
申请日:2015-08-08
申请人: DANA FARBER CANCER INST INC , BROAD INST INC , THE GENERAL HOSPITAL CORP D/B/A MASSACHUSETTS GENERAL HOSPITAL , HARVARD COLLEGE
发明人: SHAMJI ALYKHAN , SUNDBERG THOMAS , GRAY NATHANAEL , XAVIER RAMNIK , SCHREIBER STUART L , CHOI HWAN GEUN , LIANG YANKE
IPC分类号: A61K31/519 , A61K31/5377 , C07D498/02
CPC分类号: A61K31/519 , A61K31/506 , A61K31/5377 , A61K45/06
摘要: The present disclosure provides methods of treating and/or preventing inflammatory bowel disease (IBD) and graft-versus-host disease (GVHD) using salt-inducible kinase (SIK) inhibitors, such as macrocyclic SIK inhibitors of Formula (I), imidazolyl SIK inhibitors of Formula (II), and urea and carbamate SIK inhibitors of Formula (III -A) (e.g., urea and carbamate SIK inhibitors of Formula (III)).
-
公开(公告)号:EP2970360A4
公开(公告)日:2017-02-22
申请号:EP14774148
申请日:2014-03-13
IPC分类号: C07H19/16 , A61K31/708 , A61P35/00 , C07F9/6561 , C07H19/167 , C07H19/20 , C07H19/207
CPC分类号: C07H19/16 , A61K31/708 , A61K45/06 , C07F9/65616 , C07H19/167 , C07H19/20 , C07H19/207 , A61K2300/00
-
公开(公告)号:EP3172213A4
公开(公告)日:2018-01-24
申请号:EP15824907
申请日:2015-07-21
发明人: GRAY NATHANAEL , CHOI HWAN GEUN , LIANG YANKE
IPC分类号: A61K31/519 , A61P35/00 , C07D498/08 , C07D498/18
CPC分类号: C07D498/08 , C07D498/18
摘要: The present disclosure provides macrocyclic compounds of Formula (I). The provided compounds are able to bind protein kinases and may be useful in modulating (e.g., inhibiting) the activity of a protein kinase in a subject or cell and/or in treating or preventing a disease (e.g., proliferative disease, genetic disease, hematological disease, neurological disease, painful condition, psychiatric disorder, or metabolic disorder) in a subject in need thereof. Also provided are pharmaceutical compositions, kits, methods, and uses that include or involve a compound described herein.
-
公开(公告)号:EP3019491A4
公开(公告)日:2016-12-21
申请号:EP14822373
申请日:2014-07-09
发明人: GRAY NATHANAEL , CHOI HWAN GEUN , TAN LI
IPC分类号: C07D403/10 , A61K31/497 , A61K31/506 , A61P35/00 , C07D239/48 , C07D401/12 , C07D403/12 , C07D405/12 , C07D405/14 , C07D409/12 , C07D471/10 , C07D487/04
CPC分类号: C07D239/48 , A61K31/505 , A61K31/506 , A61K31/517 , A61K31/519 , A61K31/5377 , A61K45/06 , C07D401/12 , C07D403/12 , C07D405/12 , C07D405/14 , C07D409/12 , C07D409/14 , C07D471/04 , C07D487/04 , A61K2300/00
摘要: The invention relates to compounds and their use in the treatment of disease. Novel irreversible inhibitors of wild-type and mutant forms of EGFR, FGFR, ALK, ROS, JAK, BTK, BLK, ITK, TEC, and/or TXK and their use for the treatment of cell proliferation disorders are described.
-
公开(公告)号:EP3209648A4
公开(公告)日:2018-07-25
申请号:EP15852450
申请日:2015-10-22
发明人: GRAY NATHANAEL S , BUHRLAGE SARA JEAN , TREON STEVEN P , CHOI HWAN GEUN , XIONG YUAN , YANG GUANG
IPC分类号: C07D417/12 , A61K31/427 , A61K31/437 , A61K31/505 , A61P35/00 , A61P35/02 , C07D417/14 , C07D513/04
CPC分类号: C07D513/04 , A61P35/00 , A61P35/02 , C07D417/04 , C07D417/12 , C07D417/14
摘要: The present disclosure provides thiazolyl-containing compounds of Formula (I), (II), or (III). The compounds described herein may be able to inhibit protein kinases (e.g., Src family kinases (e.g., hemopoietic cell kinase (HCK)), Bruton' s tyrosine kinase (BTK)) and may be useful in treating and/or preventing proliferative diseases (e.g., myelodysplasia, leukemia, lymphoma (e.g., Waldenstrom's macroglobulinemia)) and in inducing apoptosis in a cell (e.g., malignant blood cell). Also provided in the present disclosure are pharmaceutical compositions, kits, methods, and uses including or using a compound described herein.
-
公开(公告)号:EP3171874A4
公开(公告)日:2017-12-27
申请号:EP15824975
申请日:2015-07-21
发明人: CHOI HWAN GEUN , LIANG YANKE , GRAY NATHANAEL
IPC分类号: A61K31/4178 , C07D233/88 , C07D403/04
CPC分类号: C07D403/04 , C07D403/14
摘要: The present disclosure provides imidazolyl compounds of Formula (I) and methods of preparing the compounds. The provided compounds are able to bind protein kinases and may be useful in modulating (e.g., inhibiting) the activity of a protein kinase in a subject or cell and/or in treating or preventing a disease (e.g., proliferative disease, genetic disease, hematological disease, neurological disease, painful condition, psychiatric disorder, or metabolic disorder) in a subject in need thereof. Also provided are pharmaceutical compositions, kits, methods, and uses that include or involve a compound described herein.
-
公开(公告)号:EP2440058A4
公开(公告)日:2012-11-21
申请号:EP10786967
申请日:2010-06-14
发明人: CHOI HWAN GEUN , SIM TAEBO , GRAY NATHANAEL , ZHOU WENJUN , CHANG JAE WON , ZHANG JIANMING , WEISBERG ELLEN
IPC分类号: C07D513/04 , A61K31/425 , A61P35/00
CPC分类号: C07D513/04 , A61K31/437 , A61K31/496 , A61K31/4985 , A61K31/506 , A61K31/5377
-
-
-
-
-
-